Axsome Therapeutics, Inc. (AXSM)
188.99
+4.80
(+2.61%)
USD |
NASDAQ |
Apr 17, 16:00
186.00
-2.99
(-1.58%)
After-Hours: 20:00
Axsome Therapeutics Shareholders Equity (Quarterly) : 88.30M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Madrigal Pharmaceuticals, Inc. | 602.69M |
| Insmed, Inc. | 738.98M |
| Apellis Pharmaceuticals, Inc. | 370.15M |
| Precision BioSciences, Inc. | 92.25M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 689.80M |
| Total Liabilities (Quarterly) | 601.51M |
| Debt to Equity Ratio | 2.470 |
| Current Ratio | 1.555 |
| Net Debt Paydown Yield | -0.06% |